Evofem Biosciences: Funding, Investors & Team (Oct 2026)
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Evofem Biosciences has raised $87.6M across 4 funding rounds on record, the most recent an undisclosed round of $1.0M announced in May 2024.
That round is below the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Evofem Biosciences Company Profile and Key Stats
Latest funding round on record: May 2024.
Evofem Biosciences Funding Rounds
Evofem Biosciences raised $50.0M in an undisclosed round announced in May 2021.
5 months later, a Post-IPO Equity of $10.0M was announced in Oct 2021.
7 months later, a Post-IPO Equity of $26.6M was announced in May 2022.
2 years later, an undisclosed round of $1.0M was announced in May 2024.
Evofem Biosciences Founders and Leadership Team
Contact details for the Evofem Biosciences team: 1 of 1 has an email address on file.
Start 14-day free trial →Evofem Biosciences Funding Compared to Other Biotechnology Startups
Evofem Biosciences' latest round of $1.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Evofem Biosciences in Biotechnology and San Diego
Companies Similar to Evofem Biosciences
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Evofem Biosciences Funding FAQs
What does Evofem Biosciences do?
Evofem is a biopharmaceutical company that offers women's reproductive and contraceptive care products. The company's first commercial product, Phexxi, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
How much funding has Evofem Biosciences raised?
Evofem Biosciences has raised $87.6M across 4 rounds on record. The most recent is an undisclosed round of $1.0M announced in May 2024.
When did Evofem Biosciences last raise funding?
Evofem Biosciences' most recent funding round on record is an undisclosed round of $1.0M, announced in May 2024.
Who is the CEO of Evofem Biosciences?
Saundra Pelletier is listed as CEO at Evofem Biosciences.
Where is Evofem Biosciences headquartered?
Evofem Biosciences is based in San Diego, California, United States.
How many employees does Evofem Biosciences have?
Evofem Biosciences is in the 51-100 employee band.
How does Evofem Biosciences' funding compare to other Biotechnology startups?
Evofem Biosciences' latest round of $1.0M is below the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Evofem Biosciences Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Evofem Biosciences is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.